Werbung ausblenden
Aktie

FUSION PHARMACEUTICALS

WKN
ISIN
Ticker
WKN
Ticker
ISIN
• Nasdaq
21,550 USD
+0,030 USD+0,14 %
Geld
21,650 USD
(3.300 Stk.)
Brief
21,700 USD
(100 Stk.)
Tagesvolumen
6.089.181 Stk.
Tagesspanne
21,450  –  21,590 USD
52W-Spanne
2,310  –  21,600 USD
Marktkapitalisierung
–
Dividendenrendite
–
KGV
–
Gewinn pro Aktie
–
theScreener Rating
–
Nachhaltigkeits-Score
–

Unternehmens­daten

Stammdaten zu FUSION PHARMACEUTICALS

WKN
A2P7ZZ
ISIN
CA36118A1003
Home-Symbol
FUSN
Symbol
Branche
Sektor
Unternehmen
Unbekannt
Land

Marktdaten

Marktkapitalisierung
–
Anzahl Aktien
–
Streubesitz
–

Alle Aktien des Unternehmens

NameAnzahl AktienMarktkapitalisierungakt. KursPerformancerel. Perf.
FUSION PHARMACEUTICALS
WKN A2P7ZZ · ISIN CA36118A1003 (diese Aktie)
72,41 Mio.1,45 Mrd. EUR

Anteilseigner

Federated Global Investment Management Corp.Perceptive Advisors LLCAvidity Partners Management LPDeerfield Management Co. LP (Private Equity)Fidelity Investments Canada ULCHealthCap ABPentwater Capital Management LPJohnson & Johnson Innovation - JJDC, Inc.Varian Medical Systems, Inc.OrbiMed Advisors Private EquityCanada Pension Plan Investment BoardAdams Street Partners LLCTPG Group Holdings (SBS) Advisors, Inc.Fidelity Management & Research Co. LLCMillennium Management LLCMarshall Wace LLPTIG Advisors LLCQube Research & Technologies Ltd.William Blair Investment Management LLC1832 Asset Management LP
  • Federated Global Investment Management Corp. (12,74 %)
  • Perceptive Advisors LLC (8,04 %)
  • Avidity Partners Management LP (7,66 %)
  • Deerfield Management Co. LP (Private Equity) (7,54 %)
  • Fidelity Investments Canada ULC (4,93 %)
  • HealthCap AB (4,49 %)
  • Pentwater Capital Management LP (4,46 %)
  • Johnson & Johnson Innovation - JJDC, Inc. (4,33 %)
  • Varian Medical Systems, Inc. (3,84 %)
  • OrbiMed Advisors Private Equity (3,68 %)

Kontakt

Werbung ausblenden